TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
CVEO

Civeo Corp

Consumer Cyclical · Lodging

33.80$ +2.9% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CVEO
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – -0.5% -13.9% -41.4% -15.0% -6.2% +17.3% -3.2% -23.6% -9.2% -15.8% -3.2% -26.1% +17.9%
– – +10.8% +5.5% -80.3% -9.5% +60.1% -18.5% +21.9% -9.3% +31.9% -2.3% +14.1% -37.0% +18.8%
– – +38.9% +17.5% -97.0% -77.2% +1,729.0% -62.1% -73.1% +84.8% +2.1% +26.6% -58.2% +56.6% +177.5%
– – +38.9% +17.5% -97.0% -77.2% +1,729.0% -62.1% -73.1% +84.8% +2.1% +26.6% -58.2% +56.6% +177.5%
– – -14.7% -9.9% -61.6% -8.4% +18.7% +5.1% +41.7% -9.8% +27.9% +4.3% +19.6% -37.8% +1.6%
– – +51.7% -55.6% -57.4% -44.7% +132.8% -40.5% +36.3% +5.2% +4.6% +6.8% +1.1% +7.9% -17.5%
– – +0.6% -5.8% -25.4% -15.3% -12.1% -5.0% -10.4% -17.5% -16.1% -26.1% – – –
– – -11.5% -82.7% -22.0% -20.6% -18.9% +401.9% -3.5% -92.1% -6.0% -6.5% +0.2% -9.0% +7.7%
– – -22.4% -32.8% -30.6% -20.6% -18.9% +424.8% -6.3% -10.8% -6.1% -12.7% -4.6% -14.7% +5.9%
– – -26.5% +82.7% -47.6% -14.4% -13.1% +23.5% +2.8% -23.7% -15.3% -15.2% -14.3% -25.3% +80.3%
– – -36.1% +22.0% -43.9% -9.1% +25.1% +14.6% +26.9% +6.1% +17.3% -6.3% -10.9% -18.9% -8.3%
– – +193.6% -34.6% -9.9% -11.4% +7.3% +100.8% +21.9% -3.9% -10.8% -18.3% -86.8% -3.1% +22.8%
– – -20.0% -20.1% -32.2% -14.2% +31.7% +1.9% +30.5% +13.8% +17.3% +3.6% +14.9% -31.9% +10.8%
– – -30.4% +125.4% -49.8% -11.0% -17.7% +23.4% -6.2% -33.5% -33.4% -28.1% -36.0% -33.9% +322.3%
– – +12.8% -46.1% -34.4% -15.6% +0.2% +12.4% -8.5% -23.6% -3.5% -17.0% +6.7% -26.2% -26.2%
– – – – – – – – – – – – – – –
– -91.6% +0.0% -0.4% +0.3% +0.4% +19.9% +22.5% +6.2% +1.5% +0.7% -1.6% +7.2% -4.8% -11.5%

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?